This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Lujian Tan: Innovator in Pharmaceutical Combinations
Introduction
Lujian Tan is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug combinations.
Latest Patents
Lujian Tan holds a patent for a pharmaceutical combination that includes a protein kinase C (PKC) inhibitor compound and at least one mitogen activated protein kinase (MEK) inhibitor. This combination is designed for simultaneous, separate, or sequential administration and is aimed at treating proliferative diseases. The patent outlines methods for administering a therapeutically effective amount of this combination to subjects suffering from such diseases.
Career Highlights
Lujian Tan is currently associated with Novartis AG, a leading global healthcare company. His work focuses on advancing therapeutic options for patients with proliferative diseases, showcasing his commitment to improving health outcomes through innovative solutions.
Collaborations
Lujian has collaborated with notable colleagues, including Dale Porter and Caroline Emery, who contribute to the research and development efforts within his team.
Conclusion
Lujian Tan's work in pharmaceutical combinations exemplifies the impact of innovation in healthcare. His contributions are paving the way for new treatment options for patients with proliferative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile